Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Nov 25;14(3):403–409.e3. doi: 10.1016/j.cgh.2015.09.030

Table 4.

Daily gluten intake at the clinical visit prior to tTGA seroconversion in children with celiac disease and matched controls.

Celiac disease
N=132* 		Controls
N=385
Age at 3-day food record N* Median (g/day)a (Q1,Q3) N Median (g/day)a (Q1,Q3) OR (95% CI) p-value
9 months 6 1.6 (1.4, 1.8) 17 1.9 (1.1, 2.4) 0.63 (0.19, 2.05) 0.444
12 months 32 4.9 (3.5, 5.6) 89 3.2 (2.5, 4.5) 1.58 (1.17, 2.13) 0.003
18 months 37 4.9 (3.9, 5.9) 103 3.9 (3.2, 5.2) 1.22 (0.99, 1.51) 0.077
24 months 57 5.1 (3.7, 6.2) 176 4.3 (3.3, 5.7) 1.23 (1.01, 1.49) 0.043
*

Children with data missing at the clinic visit prior to tTGA seroconversion were excluded (N=14)

a

Reported gluten intake prior to age of tTGA seroconversion in children